News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
715,494 Results
Type
Article (63782)
Company Profile (129)
Press Release (651583)
Section
Business (201107)
Career Advice (3044)
Deals (35251)
Drug Delivery (108)
Drug Development (82572)
Employer Resources (170)
FDA (16366)
Job Trends (15315)
News (344922)
Policy (33588)
Tag
Academia (2865)
Alliances (50580)
Alzheimer's disease (1384)
Approvals (16338)
Artificial intelligence (225)
Bankruptcy (321)
Best Places to Work (11838)
Breast cancer (230)
Cancer (1747)
Cardiovascular disease (137)
Career advice (2572)
CAR-T (134)
Cell therapy (386)
Clinical research (66217)
Collaboration (688)
Compensation (266)
COVID-19 (2683)
C-suite (174)
Data (1645)
Diabetes (215)
Diagnostics (6445)
Earnings (76308)
Employer resources (150)
Events (109094)
Executive appointments (597)
FDA (17300)
Funding (621)
Gene therapy (260)
GLP-1 (689)
Government (4836)
Healthcare (19675)
Infectious disease (2792)
Inflammatory bowel disease (128)
Interviews (578)
IPO (16142)
Job creations (3922)
Job search strategy (2153)
Layoffs (497)
Legal (8028)
Lung cancer (259)
Manufacturing (236)
Medical device (13432)
Medtech (13437)
Mergers & acquisitions (19515)
Metabolic disorders (563)
Neuroscience (1823)
NextGen: Class of 2025 (6975)
Non-profit (4892)
Northern California (1992)
Obesity (308)
Opinion (246)
Parkinson's disease (119)
Patents (168)
People (60783)
Phase I (20589)
Phase II (29063)
Phase III (21629)
Pipeline (708)
Postmarket research (2905)
Preclinical (8867)
Radiopharmaceuticals (253)
Rare diseases (340)
Real estate (6377)
Regulatory (22524)
Research institute (2567)
Resumes & cover letters (467)
Southern California (1743)
Startups (3584)
United States (18130)
Vaccines (651)
Weight loss (220)
Date
Last 7 days (602)
Last 30 days (2525)
Last 365 days (34251)
2025 (4549)
2024 (34992)
2023 (39552)
2022 (50617)
2021 (55660)
2020 (54659)
2019 (48549)
2018 (36901)
2017 (33555)
2016 (33457)
2015 (39143)
2014 (32845)
2013 (29149)
2012 (30590)
2011 (30451)
2010 (29294)
Location
Africa (1004)
Arizona (186)
Asia (41996)
Australia (7424)
California (4555)
Canada (1692)
China (409)
Colorado (215)
Connecticut (240)
Europe (96386)
Florida (682)
Georgia (171)
Illinois (488)
Indiana (258)
Maryland (747)
Massachusetts (3451)
Michigan (201)
Minnesota (318)
New Jersey (1355)
New York (1363)
North Carolina (875)
Northern California (1992)
Ohio (170)
Pennsylvania (1040)
South America (1339)
Southern California (1743)
Texas (690)
Utah (146)
Washington State (460)
715,494 Results for "national institute of neurological disorders and stroke".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)
Battelle, Andelyn Biosciences, Inc. , and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to manufacture suspension process gene therapy for the transformative treatment of Aspartylglucosaminuria (AGU).
November 20, 2023
·
4 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Business
Virpax Pharmaceuticals Enters into CRADA with the National Advisory Neurological Disorders and Stroke Council
Virpax ® Pharmaceuticals, Inc. today announced that it has entered into a cooperative research and development agreement (CRADA) with the National Institute of Neurological Disorders and Stroke (NINDS).
June 21, 2023
·
6 min read
Business
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
The team of Battelle, AmplifyBio and Andelyn Biosciences has won a seat on an eight-year, $149 million indefinite delivery, indefinite quantity (IDIQ) contract vehicle for the National Institute of Neurological Disorders and Stroke.
January 6, 2023
·
4 min read
Business
NexImmune Announces Research Collaboration with National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)
NexImmune, Inc. today announced a collaboration with the National Institute of Neurological Disorders and Stroke (NINDS), a division of the U.S. National Institutes of Health (NIH).
October 6, 2022
·
5 min read
Neuroscience
Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.
January 28, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Revalesio Announces New Analyses from Phase 2 RESCUE Study of RNS60 in Patients with Acute Ischemic Stroke in Oral Presentation at the International Stroke Conference 2025
February 5, 2025
·
5 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
Press Releases
DiaMedica Therapeutics Announces Publication of DM199’s Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
February 20, 2025
·
7 min read
Press Releases
International Stroke Conference 2025: Remedy Pharmaceuticals Unveils Landmark CIRARA® Data Demonstrating Significant Improvements in Stroke Outcomes
February 19, 2025
·
4 min read
1 of 71,550
Next
